EUVIMEDEUVIMED entdecken
Crossref

Pretransplant Serum Ferritin Levels and Outcomes after Myeloablative Allogeneic HSCT

Burcu Aslan Candır, Sema Seçilmiş, Samet Yaman, Ersin BOZAN, Bahar Uncu Ulu, DİCLE İSKENDER, Tuğçe Nur Yiğenoğlu, Merih Kızıl Çakar, Turgay Ulas, MEHMET SINAN DAL, Fevzi Altuntas, Fevzi Altuntas

Eastern Journal Of Medicine · 2026 · 31 (4) · 779-788

DOI: 10.5505/ejm.2026.76032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eastern Journal Of Medicine, 2026. Verfasst von Burcu Aslan Candır und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Candır, B. A., Seçilmiş, S., Yaman, S., BOZAN, E., Ulu, B. U., İSKENDER, D., Yiğenoğlu, T. N., Çakar, M. K., Ulas, T., DAL, M. S., Altuntas, F., & Altuntas, F. (2026). Pretransplant Serum Ferritin Levels and Outcomes after Myeloablative Allogeneic HSCT. Eastern Journal Of Medicine, 31(4), 779-788. https://doi.org/10.5505/ejm.2026.76032

Vancouver

Candır BA, Seçilmiş S, Yaman S, BOZAN E, Ulu BU, İSKENDER D, et al. Pretransplant Serum Ferritin Levels and Outcomes after Myeloablative Allogeneic HSCT. Eastern Journal Of Medicine. 2026;31(4):779-788. doi:10.5505/ejm.2026.76032

BibTeX
@article{Candr2026,
  author = {Candır, Burcu Aslan and Seçilmiş, Sema and Yaman, Samet and BOZAN, Ersin and Ulu, Bahar Uncu and İSKENDER, DİCLE and Yiğenoğlu, Tuğçe Nur and Çakar, Merih Kızıl and Ulas, Turgay and DAL, MEHMET SINAN and Altuntas, Fevzi and Altuntas, Fevzi},
  title = {Pretransplant Serum Ferritin Levels and Outcomes after Myeloablative Allogeneic HSCT},
  journal = {Eastern Journal Of Medicine},
  year = {2026},
  volume = {31},
  number = {4},
  pages = {779--788},
  doi = {10.5505/ejm.2026.76032}
}
Kostenlos starten →